GlassScriptPhysician profile
Constantine G Barbounis
NPI 1265416283
$1,302.13
in general payments reported to CMS, 2019-2025
12 companies · $209 in 2025
The $209 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $87.06 · 2021: $173 · 2022: $248 · 2023: $191 · 2024: $394 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $793.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $191.43 | 2023 | Miro3d |
| Biocomposites INC | $168.92 | 2024-2025 | Stimulan |
| Aroa Biosurgery Incorporated | $163.36 | 2024 | |
| Linvatec Corporation | $158.16 | 2025 | Biobrace 23mm |
| Acumed LLC | $126.27 | 2022 | |
| Integra Lifesciences Corporation | $121.76 | 2022 | |
| Bioventus LLC | $97.62 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $77.48 | 2021 | |
| Boston Scientific Corporation | $69.70 | 2020 | |
| Treace Medical Concepts, INC. | $62.10 | 2024 | |
| Smith+Nephew, INC. | $47.97 | 2021-2025 | Grafix, Stravix |
| Stimwave Technologies Incorporated | $17.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constantine Barbounis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.